Protocol Ledger

NCT06472908 · Phase III · ACTIVE NOT RECRUITING

Efficacy and Safety of Colchicine After PCI

Interventional Phase III clinical trial protocol NCT06472908 sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-07-09 Enrollment: 8,862 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06472908
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)8,862 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06472908
Protocol FieldVerified Registry Value
NCT IdentifierNCT06472908
Consolidated Lead SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment8,862 participants (ESTIMATED)
Registered Start Date2024-07-09
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI